Treatments

Treatments

Inside the First FDA-Approved CAR-T Cell Therapy

ALL patients who haven’t responded to standard care have new options on the horizon, including a type of immunotherapy called CAR T-cell therapy. Learn more from Dr. Michael Deininger.

Andrew Schorr, Michael Deininger, MD, PhD

Treatments

How Can Acute Lymphoblastic Leukemia Treatment Be Tailored?

Dr. Elias Jabbour from The University of Texas MD Anderson Cancer Center explains how patient's individual circumstances affect treatment decisions. Watch to learn from an ALL expert.

Dr Elias Jabbour

Latest News

Treatments

ALL Treatments, Transplants and Testing

Andrew Schorr, Hetty Carraway, MD, Eunice Wang, MD

Treatments

How Do I Know If I Am Eligible for a Clinical Trial?

Susan M. O'Brien, MD

Treatments

CAR-T Cells - a New Treatment Option for ALL

Dr Elias Jabbour

Treatments

How Should Immature B-cell ALL (Burkitt's Disease) Be Treated?

Dr Elias Jabbour

Treatments

What Factors Affect Your Suitability for a Radiation Treatment?

Denis-Claude Roy, MD, FRCPC

Treatments

What Is Radiation Therapy?

Denis-Claude Roy, MD, FRCPC

Treatments

How Can Steroid Therapy Help Treat Acute Leukemias?

Denis-Claude Roy, MD, FRCPC

Treatments

ALL Chemotherapy Side Effects Explained: What Happens to Body During Chemotherapy?

Ryan Cassaday, MD

Treatments

What Factors Affect My Chances of a Successful ALL Treatment?

Ryan Cassaday, MD

Treatments

What Happens When I Start ALL Treatment?

Ryan Cassaday, MD

Find a clinical trial

Learn More